Serotonin transporters: Implications for antidepressant drug development

Kellie J. White; Crystal C. Walline; Eric L. Barker

doi:10.1208/aapsj070242

Serotonin transporters: Implications for antidepressant drug development

The AAPS Journal ◽

10.1208/aapsj070242 ◽

2005 ◽

Vol 7 (2) ◽

pp. E421-E433 ◽

Cited By ~ 44

Author(s):

Kellie J. White ◽

Crystal C. Walline ◽

Eric L. Barker

Keyword(s):

Drug Development ◽

Antidepressant Drug ◽

Serotonin Transporters

Download Full-text

Serotonin Transporters: Implications for Antidepressant Drug Development

Drug Addiction ◽

10.1007/978-0-387-76678-2_13 ◽

2008 ◽

pp. 193-215

Author(s):

Kellie J. White ◽

Crystal C. Walline ◽

Eric L. Barker

Keyword(s):

Drug Development ◽

Antidepressant Drug ◽

Serotonin Transporters

Download Full-text

Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion

Current Pharmaceutical Design ◽

10.2174/1381612053382296 ◽

2005 ◽

Vol 11 (2) ◽

pp. 227-231 ◽

Cited By ~ 2

Author(s):

M. Demitrack

Keyword(s):

Drug Development ◽

Antidepressant Drug ◽

Critical Discussion

Download Full-text

New prospects in antidepressant drug development

Behavioural Pharmacology ◽

10.1097/00008877-199711000-00071 ◽

1997 ◽

Vol 8 (6) ◽

pp. 663

Author(s):

P Skolnick

Keyword(s):

Drug Development ◽

Antidepressant Drug

Download Full-text

Neuroscience Basis of Clinical Depression: Implications for Future Antidepressant Drug Development

Journal of Psychiatric Practice ◽

10.1097/01.pra.0000348365.96300.07 ◽

2009 ◽

Vol 15 (2) ◽

pp. 125-132 ◽

Cited By ~ 6

Author(s):

Sheldon H. Preskorn ◽

Wayne C. Drevets

Keyword(s):

Drug Development ◽

Antidepressant Drug ◽

Clinical Depression

Download Full-text

Galanin: New opportunities for antidepressant drug development

European Neuropsychopharmacology ◽

10.1016/s0924-977x(02)80087-6 ◽

2002 ◽

Vol 12 ◽

pp. 141-142

Author(s):

S.O. Ögren ◽

J. Kehr ◽

H. Razani ◽

T. Yoshitake ◽

N. Madjid

Keyword(s):

Drug Development ◽

Antidepressant Drug

Download Full-text

Tumor necrosis factor receptor 2: A potential target for antidepressant drug development

Clinical and Experimental Neuroimmunology ◽

10.1111/cen3.12537 ◽

2019 ◽

Vol 10 (4) ◽

pp. 272-282

Author(s):

Natasha Seymour ◽

Andrew Gibbons ◽

Brian Dean

Keyword(s):

Tumor Necrosis Factor ◽

Drug Development ◽

Tumor Necrosis ◽

Antidepressant Drug ◽

Tumor Necrosis Factor Receptor ◽

Potential Target ◽

Necrosis Factor

Download Full-text

Serotonergic gene transcriptional control regions: targets for antidepressant drug development?

The International Journal of Neuropsychopharmacology ◽

10.1017/s1461145700001747 ◽

2000 ◽

Vol 3 (1) ◽

pp. 67-79 ◽

Cited By ~ 30

Author(s):

Klaus Peter Lesch ◽

Armin Heils

Keyword(s):

Drug Development ◽

Transcriptional Control ◽

Antidepressant Drug ◽

Control Regions

Download Full-text

New Hypotheses to Guide Future Antidepressant Drug Development

Antidepressants: Past, Present and Future - Handbook of Experimental Pharmacology ◽

10.1007/978-3-642-18500-7_18 ◽

2004 ◽

pp. 519-563 ◽

Cited By ~ 2

Author(s):

I. Nalepa ◽

F. Sulser

Keyword(s):

Drug Development ◽

Antidepressant Drug

Download Full-text

Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development

CNS & Neurological Disorders - Drug Targets ◽

10.2174/187152707780363276 ◽

2007 ◽

Vol 6 (2) ◽

pp. 151-160 ◽

Cited By ~ 42

Author(s):

Keith Tanis ◽

Samuel Newton ◽

Ronald Duman

Keyword(s):

Growth Factor ◽

Drug Development ◽

Antidepressant Drug ◽

Factor Expression ◽

Growth Factor Expression

Download Full-text

Antidepressant drug development: Focus on triple monoamine reuptake inhibition

Journal of Psychopharmacology ◽

10.1177/0269881114553252 ◽

2014 ◽

Vol 29 (5) ◽

pp. 526-544 ◽

Cited By ~ 19

Author(s):

Roger M Lane

Keyword(s):

Drug Development ◽

Antidepressant Drug ◽

Reuptake Inhibition

Download Full-text